Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT01147705
Eligibility Criteria:
Inclusion Criteria:
\- stable peripheral arterial disease (demonstrated by having a reproducible pain free walking distance on 2 consecutive treadmill tests, i.e. less than 25% variance with the reason for termination of the treadmill test must be claudication pain only)
Exclusion Criteria:
* rest pain
* childbearing potential
* heart failure
* any other exercise limiting cardiac disease
* BP \> 180/100 mHg
* eGFR \< 60 ml/min
* liver disease
* malignancy
* already on allopurinol or had an adverse reaction to it
* recent marked change in symptoms or recent (in the last six months) intervention for PAD
* receiving treatment with either 6-mercaptopurine, azathioprine, warfarin, or theophylline
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
85 Years
Study:
NCT01147705
Study Brief:
Protocol Section:
NCT01147705